Tyme Receives Notice of Allowance of Patent for SM-88 in China
NEW YORK, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Tyme Technologies Inc. (NASDAQ:TYME), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today announced that the State Intellectual Property Office of China …